XP

XP (XP) Is Up - What Are Investors Seeing in This Stock?

This evening we watched XP rise 12.4% to a price of $12.3 per share. The large-cap Capital Markets company is now trading -34.36% below its average target price of $18.74. Analysts have set target prices ranging from $13.94 to $24.88 per share for XP, and have given the stock an average rating of buy.

XP has an average level of shares sold short, at 5.9% of its total share float. The stock's short ratio (also called days to cover) is 2.34. Since 19.35% of the company's shares are owned by insiders, we can infer that there is a degree of alignment between management and shareholder interests.

Institutional investors own 70.8% of XP's shares, which indicates they have a high level of confidence in the company.

Institutions Invested in XP

Date Reported Holder Percentage Shares Value
2022-12-31 Capital World Investors 7% 33,495,084 $411,989,539
2022-12-31 Dodge & Cox Inc 7% 29,769,631 $366,166,466
2022-12-31 General Atlantic, L.P. 6% 25,317,733 $311,408,120
2022-12-31 Mawer Investment Management Limited 4% 18,132,832 $223,033,837
2022-12-31 FMR, LLC 4% 17,370,289 $213,654,558
2022-12-31 Price (T.Rowe) Associates Inc 3% 14,666,096 $180,392,983
2022-12-31 Harding Loevner LLC 3% 14,375,095 $176,813,671
2022-12-31 JP Morgan Chase & Company 3% 12,713,739 $156,378,992
2022-12-31 Squadra Investments - Gestao De Recursos Ltda 3% 12,567,890 $154,585,049
2022-12-31 Sands Capital Management, LLC 2% 8,694,111 $106,937,566
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.

IN FOCUS